|
NIPSNAP3B expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.228800E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.791300E-04 |
| Normal-vs-Stage2 |
8.962000E-03 |
| Normal-vs-Stage3 |
2.09469999999934E-05 |
| Normal-vs-Stage4 |
1.639730E-02 |
| Stage1-vs-Stage2 |
8.487800E-01 |
| Stage1-vs-Stage3 |
4.010200E-02 |
| Stage1-vs-Stage4 |
7.119600E-01 |
| Stage2-vs-Stage3 |
2.352400E-01 |
| Stage2-vs-Stage4 |
6.979600E-01 |
| Stage3-vs-Stage4 |
6.036200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.350230E-04 |
| Normal-vs-AfricanAmerican |
8.964200E-03 |
| Normal-vs-Asian |
5.414000E-02 |
| Caucasian-vs-AfricanAmerican |
3.561700E-02 |
| Caucasian-vs-Asian |
8.460200E-01 |
| AfricanAmerican-vs-Asian |
3.997600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.154300E-04 |
| Normal-vs-Female |
7.241400E-04 |
| Male-vs-Female |
7.736800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
8.634100E-04 |
| Normal-vs-Extreme_Weight |
2.14469999999523E-05 |
| Normal-vs-Obese |
1.802060E-03 |
| Normal-vs-Extreme_Obese |
2.083900E-02 |
| Normal_Weight-vs-Extreme_Weight |
7.263400E-01 |
| Normal_Weight-vs-Obese |
6.218400E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.780400E-01 |
| Extreme_Weight-vs-Obese |
3.501800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.578400E-01 |
| Obese-vs-Extreme_Obese |
6.556400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.117620E-03 |
| Normal-vs-Age(41-60Yrs) |
1.441700E-03 |
| Normal-vs-Age(61-80Yrs) |
1.28170000002203E-06 |
| Normal-vs-Age(81-100Yrs) |
1.211880E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.190400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.753800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.766000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.061180E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.491000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.978600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.138930E-03 |
| Normal-VS-Type2 PRCC |
2.76769999996151E-06 |
| Normal-VS-KIRP CIMP |
2.353100E-04 |
| Normal-VS-Unclassified PRCC |
2.659700E-03 |
| Type1 PRCC-VS-Type2 PRCC |
1.6719599999937E-05 |
| Type1 PRCC-VS-KIRP CIMP |
1.854990E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
9.114200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
7.769600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.718140E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
2.400400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.61199999999728E-05 |
| Normal-vs-N1 |
1.743540E-03 |
| Normal-vs-N2 |
4.207500E-02 |
| N0-vs-N1 |
4.335800E-01 |
| N0-vs-N2 |
5.471200E-01 |
| N1-vs-N2 |
4.087000E-01 |
|
|
